Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB123667 vs Chemotherapy in Platinum-Resistant Ovarian Cancer
NCT07214779Phase 3Recruiting
- Sponsor
- Incyte
- Start
- Dec 2025
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of INCB123667 in ovarian cancer, sponsored by Incyte. Started Dec 2025; status: recruiting.
02
Drugs
INCB123667
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07214779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214779.